CD19 and myeloid sarcoma: There were 2 sets of transcriptome datasets of CD19+ B cells and CD4+ T cells from MS patients before and after the application of Fingolimod and 2 sets of transcriptome datasets of pDCs and PBMC from MS patients before and after the application of IFN-β (GSE81604 (32, 33), GSE73079 (32–34), GSE37750 (30), GSE33464 (35, 36)).